| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |